May 04, 2026

3A Financial Buying / Selling Down Town Hospital ,Gujarat NRE Mineral ,Infinium Precious Resources Maxvalue Credits Others ,

3A Financial Services deals in Unlisted Shares & Securities .

Following are the scripts that is trading in unlisted market-

  

     1)  Down Town Hospital Limited

 

              2) Gujarat NRE Mineral Resources Limited

                     3) Infinium Precious Resources Limited

 

          4)   Maxvalue Credits and Investments Limited

 

 





Contact us to buy unlisted shares – 9867572101

 

May 03, 2026

Shervani Industrial Syndicate Listed - A Hidden Gem ? Please Only Study

 

 

 

New post 

 Shervani Industrial Syndicate Does Well- Q1-2027 EPS Rs.5 /17 p , Company - Asset Laden ? 

Please click ;-

http://www.rareindianshares.info/2026/08/shervani-industrial-syndicate-does-well_01374927467.html

------------

Original Post

Building  High End / Premium Flats in Prayagraj- Allahabad

Please click ;-

https://sherwaniind.ssls1.com/

It appears  that a Real Estate  company cannot include in its accounts the profit made from a sale of flat etc till a Conveyance / Registration Deed is registered  -PLEASE RECHECK this point

Turnover / profits of the company can jump if more Registrations are done

Other Highlights

Very low Debt / Equity Ratio

High Promoters' Holding

-----------------

In 2023-2024. EPS was Rs 115 - Page 55 Annual Report 2024-2025

 In 2023-2024 Dividend was 200% Rs 20/ share -Page 71 Annual Report 2024-2025

----------

Share Capital around Rs 2 cr 59 lakh Share Rs 10 paid

Reserves Rs 127 cr 38 lakh

Book Value Rs 491 / share

CMP Around Rs 325 / share

Source

Annual Report 2024-2025

https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9592b7b-988d-4039-a3ad-737f1e74c6b7.pdf

Also setting up a 100 bed Hospital and a Holiday Resort

Page 23- Annual Report 2024-2025

 ---------------

Shervani Hotels- Star Hotels P Ltd

  https://www.shervanihotels.com/nehru-place-new-delhi/

-----------

Blog Comments

 Please consult an Investment Expert Before  Taking any Investment Decision
General Warning : Investment in Shares Can be Injurious to Your Wealth

All facts stated in good faith. Please recheck all points before taking any investment decision ( No responsibility with the writer or blog )

CAUTION : The writer has in his / family members' names holding in this Company. So make adequate " provisions " for any over optimism

---------------

old post

HISTORY

Established in 1948 , at Allahabad , by the deeply patriotic and enterprising Shervani family , GEEP ( Great Eastern Electro Plating ) sought to contribute to independent India's self reliance in electroplating industry. Electroplating technology was used by it for manufacturing torches ( famous Geep brand ).In due course it began to produce batteries. In the post globalization scenario , Geep sold out its traditional torch / battery business to Multinational- Gillette.



After closing down its battery / torches manufacturing facility at Allahabad , Shervani Industrial Syndicate Ltd. is , currently , in the process of selling machinery . It proposes to develop its very substantial and highly valuable land for REAL ESTATE projects.

To the best of our knowledge ( which please recheck ) the extent of land bank of Shervani Industrial Syndicate Limited in the posh Suleman Serai area of Allahabad is between 30 to 35 acres.

Shervani Industrial Syndicate is cash rich . Its sticky investment in Shervani Sugar Syndicate Ltd. have been provided for. There may be some gains  by way of recovery of amounts earlier provided for in the Books of Account here as sugar prospects had improved substantially .

Tara Snacks And  Foods Ltd. ( now renamed Farco Foods Limited) , a loss making entity ,is its subsidiary.

Another associate Company Shervani Hospitalities Ltd ( of which Shervani Industrial holds shares ) which has hotels in Nainital, New Delhi etc ( Nehru Place Hotel opening shortly )should be doing well as Hotel prospects have improved greatly

Hero Fincorp 2025-2026 Results

 Please click ;-

https://hfcl-website-cms.s3.ap-south-1.amazonaws.com/HFCL_Audited_Financial_Results_March_31_2026_5f05a61f92.pdf

 Official site

https://www.herofincorp.com/

Blog Comments 

Some pre IPO  shares of Hero Fincorp  are available for Sale / Purchase with Dealers of Rare Indian Shares

May 02, 2026

Altius Investech on API Holdings - Message Received

Blog Disclaimer  ; Message as Received. 

Please Recheck all facts

-----------------

MESSAGE

 

 

API Holdings: From Losses to Profitability — FY26 Turnaround Story

We present API Holdings Ltd. — a leading digital healthcare platform operating across B2B pharma distribution (Ascent & Aknamed), B2C consumer platform (PharmEasy), and diagnostics (Thyrocare), creating a fully integrated healthcare ecosystem across India.

 

🌐 Business Overview

Diversified platform across supply chain, consumer & diagnostics

  • B2B: Supplies medicines to chemists, hospitals & institutions
  • B2C:PharmEasy enables online medicine delivery & healthcare access
  • Diagnostics:Thyrocare offers nationwide testing with strong margins
  • End-to-end presence across manufacturers → hospitals → consumers 

 

📊 9MFY26 Financial Turnaround

Clear shift from losses to profitability

  • Revenue at ₹5,095 Cr, up +15% YoY 
  • EBITDA turned positive at ₹29 Cr vs losses earlier
  • Finance cost reduced to ₹340 Cr (-14% YoY)
  • PBT losses narrowed by 38% YoY

 

👑 Thyrocare — Core Driver of Turnaround

High-margin diagnostics business powering profitability

  • Revenue: ₹605 Cr, up +21% YoY
  • Gross margin: 73% (among highest in diagnostics)
  • EBITDA: ₹201 Cr with 33% margin
  • Consistent quarterly margins (32–35%) supporting group EBITDA

👉 Thyrocare is the primary cash engine enabling the group’s EBITDA turnaround

 

🚚📱 Other Segments Improving Rapidly

B2B & B2C showing sharp operational recovery

  • B2B Revenue: ₹3,043 Cr (+16% YoY); EBITDA loss reduced by 75%
  • First EBITDA-positive quarter achieved in Q3FY26
  • B2C Revenue: ₹983 Cr (+18% YoY); gross margins expanded to 25%
  • EBITDA losses narrowed to ₹34 Cr vs ₹47 Cr YoY

Latest From Social Media

 

 For any assistance, feel free to contact our support team at +918240614850 or support@altiusinvestech.com

 

 

May 01, 2026

Altius Investech on Hexagon Nutrition - Message Received

 

Blog Disclaimer  ; Message as Received. 

Please Recheck all facts

-----------------

MESSAGE

 

 

Hexagon Nutrition: ₹325 Cr Revenue | Strong Profit Growth & Global Expansion Story

 We are pleased to present Hexagon Nutrition Ltd. — a research-driven, pure-play nutrition company focused on clinical nutrition, micronutrient premixes, and therapeutic solutions, playing a vital role in addressing global nutritional deficiencies across 80+ countries.
 
📊 Scale & Financial Performance

Hexagon continues to demonstrate strong operating momentum with sharp improvement in profitability.

    Revenue at ~₹325 Cr, up ~9% YoY
    EBITDA at ~₹40 Cr, up ~61% YoY
    PAT at ~₹24 Cr, nearly doubling (~98% YoY growth)
    Margin expansion driven by branded portfolio and operating leverage

 
🌍 Global Presence & Product Strength

A diversified nutrition platform with strong global reach and category depth.

    Presence across 80+ countries with exports and institutional partnerships
    Portfolio spanning clinical nutrition, therapeutic nutrition, and micronutrient premixes
    Flagship brands including PentaSure, Obesigo, and Pediagold addressing diverse health needs
    Serves 1,000+ healthcare institutions globally

 
⚙️ Integrated Platform & R&D Strength

Fully integrated operations supported by strong scientific capabilities.

    End-to-end capabilities from R&D to manufacturing and distribution
    4 manufacturing facilities (India + Uzbekistan) ensuring global supply
    NABL & ISO-certified analytical labs ensuring quality and compliance
    Dedicated R&D team driving science-backed, customized formulations

 
🚀 Growth Drivers & Strategic Focus

Clear roadmap focused on premiumisation, innovation, and global expansion.

    Expansion of premium clinical nutrition portfolio (PentaSure variants, Nutrone range)
    Strong growth in branded segment (~30% YoY) and premix exports (~19% YoY)
    Increasing penetration across hospitals, pharmacies, and e-commerce channels
    Strategic focus on emerging markets, fortification, and preventive healthcare

­     

Follow us on social media to keep yourself updated!
Latest From Social Media
­
   
Follow Us on Linkedin
­
    ­
    
    ­
    
    ­
    
    ­
    
    ­
    

 

 For any assistance, feel free to contact our support team at +918240614850 or support@altiusinvestech.com